• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 and CLL in Sweden: lessons learned?

作者信息

Mulligan Stephen P

机构信息

Hematology, Royal North Shore Hospital, Sydney, Australia.

出版信息

Blood Adv. 2025 Jul 8;9(13):3223-3225. doi: 10.1182/bloodadvances.2025016266.

DOI:10.1182/bloodadvances.2025016266
PMID:40569632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277786/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe3/12277786/7a07c8a9ce03/BLOODA_ADV-2025-016266-C-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe3/12277786/7a07c8a9ce03/BLOODA_ADV-2025-016266-C-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe3/12277786/7a07c8a9ce03/BLOODA_ADV-2025-016266-C-gr1.jpg

相似文献

1
COVID-19 and CLL in Sweden: lessons learned?瑞典的新冠病毒肺炎与慢性淋巴细胞白血病：有何经验教训？
Blood Adv. 2025 Jul 8;9(13):3223-3225. doi: 10.1182/bloodadvances.2025016266.
2
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era.慢性淋巴细胞白血病中新冠疫情的结果：聚焦极早期和奥密克戎时代。
Blood Adv. 2025 Jul 8;9(13):3170-3181. doi: 10.1182/bloodadvances.2024015260.
3
COVID-19 vaccination likelihood among federally qualified health center patients: Lessons learned for future health crises.联邦合格健康中心患者对 COVID-19 疫苗接种的可能性：为未来的健康危机吸取的教训。
Am J Med Sci. 2023 Nov;366(5):321-329. doi: 10.1016/j.amjms.2023.07.013. Epub 2023 Aug 22.
4
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis.慢性淋巴细胞白血病患者中SARS-CoV-2疫苗接种的免疫反应动力学：一项描述性分析
Front Immunol. 2025 Jun 6;16:1571680. doi: 10.3389/fimmu.2025.1571680. eCollection 2025.
5
The aftermath of COVID-19: Mortality impact of the pandemic on older persons in Sweden and other Nordic countries, 2020-2023.新冠疫情的后果：2020 - 2023年大流行对瑞典及其他北欧国家老年人的死亡率影响
Scand J Public Health. 2024 Jun 10:14034948241253339. doi: 10.1177/14034948241253339.
6
Lessons learned from terror attacks: thematic priorities and development since 2001-results from a systematic review.从恐怖袭击中吸取的教训：2001 年以来的主题优先事项和发展——系统评价的结果。
Eur J Trauma Emerg Surg. 2022 Aug;48(4):2613-2638. doi: 10.1007/s00068-021-01858-y. Epub 2022 Jan 13.
7
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients.从恢复期血浆治疗 COVID-19 中获得的经验教训以及免疫功能低下患者的具体注意事项。
Transfus Apher Sci. 2022 Jun;61(3):103355. doi: 10.1016/j.transci.2022.103355. Epub 2022 Jan 13.
8
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.SARS-CoV-2 mRNA 疫苗接种在慢性淋巴细胞白血病患者中引发渐进性免疫功能障碍：一项前瞻性队列研究。
PLoS Med. 2023 Jun 29;20(6):e1004157. doi: 10.1371/journal.pmed.1004157. eCollection 2023 Jun.
9
Lessons Learned from the COVID-19 Pandemic in Nursing Homes: A Systematic Review.养老机构中 COVID-19 疫情的经验教训：系统评价。
Int J Environ Res Public Health. 2022 Dec 16;19(24):16919. doi: 10.3390/ijerph192416919.
10
En Route Critical Care Evacuations From Rarely Utilized Partner Medical Treatment Facilities: A Case Series With Lessons Learned.从很少使用的合作医疗机构进行途中重症监护后送：一个病例系列及经验教训
Mil Med. 2023 Jul 22;188(7-8). doi: 10.1093/milmed/usac079. Epub 2022 Mar 29.

本文引用的文献

1
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era.慢性淋巴细胞白血病中新冠疫情的结果：聚焦极早期和奥密克戎时代。
Blood Adv. 2025 Jul 8;9(13):3170-3181. doi: 10.1182/bloodadvances.2024015260.
2
Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL.在 CLL 和 MBL 患者中，多次接种 COVID-19 疫苗以达到最大抗体反应，可显著降低死亡率和住院率。
Br J Haematol. 2024 Feb;204(2):487-491. doi: 10.1111/bjh.19087. Epub 2023 Sep 5.
3
Comparing COVID-19 pandemic health responses in two high-income island nations: Iceland and New Zealand.
比较两个高收入岛国在 COVID-19 大流行期间的卫生应对措施：冰岛和新西兰。
Scand J Public Health. 2023 Jul;51(5):797-813. doi: 10.1177/14034948221149143. Epub 2023 Jan 30.
4
High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients.住院COVID-19患者中低计数单克隆B细胞淋巴细胞增多症的高发生率。
Blood. 2023 Jan 19;141(3):309-314. doi: 10.1182/blood.2022017439.
5
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.在 CLL 和 MBL 患者中接种多次 COVID-19 疫苗可提高免疫应答，具有渐进性和高血清转化率。
Blood. 2022 Dec 22;140(25):2709-2721. doi: 10.1182/blood.2022017814.
6
How Sweden approached the COVID-19 pandemic: Summary and commentary on the National Commission Inquiry.瑞典应对 COVID-19 大流行的措施：国家委员会调查总结和评论。
Acta Paediatr. 2023 Jan;112(1):19-33. doi: 10.1111/apa.16535. Epub 2022 Sep 15.
7
Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management.单克隆B细胞淋巴细胞增多症——诊断标准、生物学特性、自然史及临床管理综述
Leuk Lymphoma. 2022 Dec;63(12):2795-2806. doi: 10.1080/10428194.2022.2092857. Epub 2022 Jun 29.
8
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era.在奥密克戎时代，CLL 患者因 COVID-19 而死亡的风险较低。
Blood. 2022 Aug 4;140(5):445-450. doi: 10.1182/blood.2022016147.
9
COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity.COVID-19 疫苗在慢性淋巴细胞白血病和单克隆 B 淋巴细胞增多症中的失败；体液和细胞免疫。
Br J Haematol. 2022 Apr;197(1):41-51. doi: 10.1111/bjh.18014. Epub 2022 Jan 5.